Akari Therapeutics AKTX SEC Filings

NASDAQ AKTX
$10.57 -0.39 (-3.56%)
At close: Sep 9, 2026 · 4:00 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Akari Therapeutics Plc (AKTX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index